Datos a fecha 10/05/26 23:26
| Ticker | TEVA |
|---|---|
| ISIN | US8816242098 |
| Sector | Atención sanitaria |
| Industria | Drug Manufacturers - Specialty & Generic |
| Mercado | NYSE |
| Capitalización | US$41,604,975,710 |
| Beta | 0.86 |
| Sitio web | https://www.tevapharm.com |
| CEO | Richard D. Francis |
| Fecha de IPO | 16/02/1982 |
| País | IL |
| Dirección | 124 Dvora Hanevi'a Street, Tel Aviv, 6944020 |
| Volumen | 4,463,132 |
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells...
El precio actual de Teva Pharmaceutical (TEVA) es de 35.73, con una variación del -0.78%.
Las acciones de Teva Pharmaceutical cotizan en la bolsa de valores NYSE.
El símbolo bursátil de Teva Pharmaceutical es "TEVA".
Teva Pharmaceutical no paga dividendos.
La capitalización de mercado de Teva Pharmaceutical es 41,931,015,262.
El BPA de Teva Pharmaceutical es 1.23.
Teva Pharmaceutical opera en el sector Healthcare, industria Drug Manufacturers - Specialty & Generic.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones